Back to Search
Start Over
DMF: a promising therapeutic option in CTCL.
- Source :
-
Blood . 8/11/2016, Vol. 128 Issue 6, p745-746. 2p. - Publication Year :
- 2016
-
Abstract
- The article discusses research on the therapeutic use of dimethyl fumarate (DMF) in cutaneous T-cell lymphoma (CTCL). Topics discussed include therapeutic option DMF in CTCL treatment, the characteristic of malignant T cells, the restoration of apoptosis in CTCL cells using DMF, and the clinical trial for CTCL patients.
Details
- Language :
- English
- ISSN :
- 00064971
- Volume :
- 128
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 117399601
- Full Text :
- https://doi.org/10.1182/blood-2016-06-722462